» Articles » PMID: 15315850

Tetanus and Diphtheria Antibodies and Response to a Booster Dose in Brazilian HIV-1-infected Women

Overview
Journal Vaccine
Date 2004 Aug 19
PMID 15315850
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Tetanus and diphtheria (Td) antibodies were studied in HIV-1-infected women during puerperium. HIV group (n=61) was compared with Control group (n=101). Twenty-one women from HIV and 13 from Control group who had antibody levels lower than 0.1 IU/mL received a booster with Td vaccine. Antibodies were assessed by double antigen ELISA. Mean tetanus and diphtheria antibody levels from HIV group were lower than those from Control group. Multiple linear regression analysis showed that tetanus and diphtheria antibody levels were decreased by HIV-1-infection, and that was independent of the reduction due to the time interval between last booster and antibody assessment. After a booster dose, both groups had an increase in mean tetanus and diphtheria antibody levels, but in Control group the levels were higher than in HIV group.

Citing Articles

Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.

Tortellini E, Fosso Ngangue Y, Dominelli F, Guardiani M, Falvino C, Mengoni F Viruses. 2023; 15(9).

PMID: 37766251 PMC: 10534440. DOI: 10.3390/v15091844.


HIV infection and the implication for COVID-19 vaccination.

Oyelade T, Purnama Raya R, Latief K Public Health Chall. 2023; 1(3):e14.

PMID: 37521727 PMC: 9353425. DOI: 10.1002/puh2.14.


Living with HIV and Getting Vaccinated: A Narrative Review.

De Vito A, Colpani A, Trunfio M, Fiore V, Moi G, Fois M Vaccines (Basel). 2023; 11(5).

PMID: 37243000 PMC: 10220625. DOI: 10.3390/vaccines11050896.


SARS-CoV-2 immunity and vaccine strategies in people with HIV.

Mullender C, da Costa K, Alrubayyi A, Pett S, Peppa D Oxf Open Immunol. 2023; 3(1):iqac005.

PMID: 36846557 PMC: 9452103. DOI: 10.1093/oxfimm/iqac005.


Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

Crum-Cianflone N, Sullivan E Infect Dis Ther. 2017; 6(3):303-331.

PMID: 28779442 PMC: 5595780. DOI: 10.1007/s40121-017-0166-x.